Cashman,
lab quality and lab sensitivity are two different things.
Roche and Abbott large lab analysers beat this current test by over an order of magnitude. M&G will more likely be in the highly sensitive test that's under development and comparable to these large analysers, that's where the technology really shines through. Not sure about the first cartridge to be reeased though, maybe/maybe not, lets see what Anteo team can pull off.
Cashman, lab quality and lab sensitivity are two different...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $33.18K | 1.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2717347 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 723484 | 6 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |